You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 19, 2025

Drug Price Trends for NDC 00527-1502


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00527-1502

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for Prescription Drugs: A Focus on NDC 0527-1502

Introduction to Prescription Drug Markets

The prescription drug market is a complex and dynamic sector, influenced by various factors including competition, regulatory changes, and technological advancements. Understanding the market dynamics is crucial for predicting price trends and managing pharmaceutical expenditures.

Overview of the Prescription Drug Market

The prescription drug market can be broadly categorized into small molecule drugs and biological products. Small molecule drugs are typically cheaper and more widely available, whereas biological products are often more expensive and complex to produce[1].

Competition in Prescription Drug Markets

Competition plays a significant role in determining drug prices. Drugs with multiple manufacturers generally have lower prices compared to those with only one manufacturer. For instance, in 2022, 43% of small molecule drugs had only one manufacturer, accounting for 65% of small molecule drug expenditures. This indicates that monopolistic practices can significantly impact pricing[1].

Specialty Drugs and Their Impact

Specialty drugs, which include many biological products, are a significant segment of the market. Between 2017 and 2022, total inflation-adjusted expenditures on specialty drugs increased by 39.9%, despite a 6.2% decrease in the number of specialty prescriptions. This resulted in a 49.2% increase in spending per specialty prescription[1].

Drug Price Inflation Projections

Recent projections indicate that drug price inflation is expected to continue. Vizient Inc. projects a 3.81% overall drug price inflation rate for 2025, driven in part by the expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies[2][4].

Specifics of NDC 0527-1502

NDC 0527-1502 corresponds to a medication containing Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate, commonly used for attention deficit hyperactivity disorder (ADHD) and narcolepsy.

Market Analysis for NDC 0527-1502

Competition Level

To analyze the price projections for NDC 0527-1502, it is essential to understand the competition level for this specific drug. If this drug has multiple manufacturers, it is likely to have lower prices compared to drugs with a single manufacturer. However, specific data on the number of manufacturers for this NDC is not provided in the available sources.

Pricing Trends

Given the general trend of increasing drug prices, especially for specialty and high-demand medications, it is reasonable to expect that the price of NDC 0527-1502 could rise. The projected 3.81% drug price inflation rate for 2025 suggests that prices for many prescription drugs, including those in high demand like ADHD medications, may increase[2].

Regulatory and Market Factors

Regulatory changes and market dynamics can also impact prices. For example, the introduction of biosimilars can reduce prices for biological products, but this may not directly affect small molecule drugs like NDC 0527-1502. However, any changes in formulary strategies by pharmacy benefit managers could influence the pricing and availability of this medication[4].

Price Projections

Given the lack of specific data on NDC 0527-1502, we can make a general projection based on overall market trends:

  • Short-term Projections: For 2025, a price increase in line with the projected 3.81% drug price inflation rate is plausible.
  • Long-term Projections: Over the next few years, prices may continue to rise due to increasing demand and potential shortages, although the introduction of generic versions or changes in regulatory policies could mitigate these increases.

Key Takeaways

  • Competition: The number of manufacturers for a drug significantly impacts its price.
  • Specialty Drugs: These drugs, including many biological products, are driving a significant portion of the increase in prescription drug expenditures.
  • Price Inflation: A projected 3.81% increase in drug prices for 2025 suggests ongoing upward pressure on prescription drug costs.
  • Regulatory and Market Factors: Changes in formulary strategies and the introduction of biosimilars or generic versions can influence pricing.

FAQs

1. What is the primary factor influencing prescription drug prices? The primary factor is the level of competition in the market, with drugs having multiple manufacturers generally having lower prices.

2. How are specialty drugs impacting the prescription drug market? Specialty drugs are driving a significant increase in expenditures, despite a decrease in the number of prescriptions, leading to higher spending per prescription.

3. What is the projected drug price inflation rate for 2025? The projected drug price inflation rate for 2025 is 3.81%, according to Vizient Inc.

4. How do biosimilars affect the market for biological products? Biosimilars are expected to increase in market share, potentially reducing prices for biological products, although their impact on small molecule drugs is minimal.

5. What are the potential long-term price projections for NDC 0527-1502? Prices may continue to rise due to increasing demand and potential shortages, but the introduction of generic versions or changes in regulatory policies could mitigate these increases.

Sources

  1. Competition in Prescription Drug Markets, 2017-2022 - ASPE
  2. Vizient Projects Drug Price Inflation at 3.81% - Vizient Inc.
  3. 5 Predictions for the Biopharma and Biotech Industries in 2025 - TFS CRO
  4. Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals - Vizient Inc.
  5. NDC 0527-1502 Oral Tablet Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate - FDA Report

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.